Last reviewed 2026-04-20 · How we verify

DOMIPHEN

FDA-approved active Small molecule Quality 6/100

DOMIPHEN is a domiphen drug. It is currently FDA-approved.

At a glance

Generic name	DOMIPHEN
Drug class	domiphen
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study Evaluating the Efficacy and Safety of Miconazole Nitrate + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal Candidiasis (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

DOMIPHEN CI brief — competitive landscape report
DOMIPHEN updates RSS · CI watch RSS

Frequently asked questions about DOMIPHEN

What is DOMIPHEN?

DOMIPHEN is a domiphen drug.

What drug class is DOMIPHEN in?

DOMIPHEN belongs to the domiphen class. See all domiphen drugs at /class/domiphen.

What development phase is DOMIPHEN in?

DOMIPHEN is FDA-approved (marketed).

Drug class: All domiphen drugs
Therapeutic area: All drugs in Other

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing